首页> 外文期刊>Journal of Gynecologic Oncology >Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer
【24h】

Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer

机译:初治宫颈癌患者大剂量率近距离放疗后阴道苍白反应在预测晚期阴道狭窄中的作用

获取原文
           

摘要

Objective To assess actual rates of late vaginal stenosis and identify predisposing factors for complications among patients with previously untreated cervical cancer following high-dose-rate brachytherapy. Methods We performed longitudinal analyses of 57 patients using the modified Dische score at 6, 12, 18, 24, 36, and 60 months after treatment, which consisted of 15 interstitial brachytherapys and 42 conventional intracavitary brachytherapys, with a median follow-up time of 36 months (range, 6 to 144 months). Results More than half of the patients developed grade 1 (mild) vaginal stenosis within the first year of follow-up, and grade 2 (97.5%, moderate) to grade 3 (severe) stenosis gradually increased with time. Actual stenosis rates for grade 1, 2, and 3 were 97.5% (95% confidence interval [CI], 92.7 to 97.5), 60.7% (95% CI, 42.2 to 79.3), and 7.4% (95% CI, 0 to 18.4) at 3 years after treatment. Pallor reaction grade 2-3 at 6 months was only a statistically significant predisposing factor for grade 2-3 late vaginal stenosis 3 years or later with a hazard ratio of 3.48 (95% CI, 1.32 to 9.19; p=0.018) by a multivariate Cox proportional hazard model. Patients with grade 0-1 pallor reaction at 6 months showed a grade ≥2 vaginal stenosis rate of 53%, whereas the grade 2-3 pallor reaction group achieved a grade ≥2 vaginal stenosis rate at 3 years at 100% (p=0.001). Conclusion High-dose-rate brachytherapy was associated with high incidence of late vaginal stenosis. Pallor reaction grade 2-3 at 6 months was predictive of late grade 2-3 vaginal stenosis at 3 years after treatment. These findings should prove helpful for patient counseling and preventive intervention.
机译:目的评估高剂量率近距离放射治疗后未接受治疗的子宫颈癌患者中晚期阴道狭窄的实际发生率,并确定并发症的诱因。方法我们采用改良的Dische评分在治疗后6、12、18、24、36和60个月对57例患者进行了纵向分析,包括15种间质近距离放射治疗和42例常规腔内近距离放射治疗,中位随访时间为15个月。 36个月(范围从6到144个月)。结果超过一半的患者在随访的第一年内出现1级(轻度)阴道狭窄,而2级(97.5%,中度)至3级(重度)狭窄随时间逐渐增加。 1、2和3级的实际狭窄率分别为97.5%(95%置信区间[CI]为92.7至97.5),60.7%(95%CI为42.2至79.3)和7.4%(95%CI为0至0。 18.4)在治疗后3年。 6个月时2-3级的Pallor反应只是3年或更晚的2-3级晚期阴道狭窄的统计学显着诱因,多元危险率为3.48(95%CI,1.32至9.19; p = 0.018)考克斯比例风险模型。在6个月内出现0-1级苍白反应的患者显示2级阴道狭窄率为53%,而2-3级苍白反应组在100%的情况下在3年内达到了≥2级阴道狭窄(p = 0.001 )。结论大剂量近距离放射治疗与晚期阴道狭窄的高发有关。在治疗后3年,在6个月时出现2-3级Pallor反应可预测晚期2-3级阴道狭窄。这些发现应被证明有助于患者咨询和预防干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号